Can Emerging Markets Fuel Growth And Restore Trust In Pharma?
This article was originally published in PharmAsia News
Executive Summary
When looking at emerging markets, most biopharma analysts focus on commercial opportunities - whether "pharmerging" markets will help mitigate lost sales in the U.S. and Europe stemming from the patent cliff, increasing pressure from payers and related challenges